Riesgo EJR

Language: Spanish
References: 9
Page: 38-42
PDF size: 279.29 Kb.

Text Extraction

No abstract.

REFERENCES

1. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, and Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.

2. Charpentier E, and Doudna JA (2013) Biotechnology: Rewriting a genome. Nature 495: 50-51.

3. Doudna JA, and Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346: 1258096.

4. Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DB, Shmakov S, Makarova KS, Semenova E, Minakhin L, Severinov K, Regev A, Lander ES, Koonin EV, Zhang F (2016) C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science doi: 10.1126/ science.aaf5573.

5. Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E, Horvath P, Moineau S, Mojica FJ, Wolf YI, Yakunin AF, van der Oost J, Koonin EV (2011) Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9: 467-477.

6. Horii T, Hatada I (2016) Production of genomeedited pluripotent stem cells and mice by CRISPR/Cas [Review]. Endocr J 63: 213-219.

7. Kondo S, Ueda R (2013) Highly improved gene targeting by germline-specific Cas9 expression in Drosophila. Genetics 195: 715-721.

8. Liang P, Xu Y, Zhang X, Ding C, Huang R, Zhang Z, Lv J, Xie X, Chen Y, Li Y, Sun Y, Bai Y, Songyang Z, Ma W, Zhou C, Huang J (2015) CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 6: 363-372.

9. Wade M (2015) High-Throughput Silencing Using the CRISPR-Cas9 System: A Review of the Benefits and Challenges. J Biomol Screen 20: 1027-1039.